logo

Acelrx Pharmaceuticals Inc. (ACRX)



Trade ACRX now with
  Date
  Headline
11/13/2019 7:04:02 AM AcelRx Pharma Announces Publication Analyzing Pooled Dosing And Efficacy Data On Sufentanil Sublingual 30 Mcg Tablets
6/3/2019 7:07:57 AM AcelRx Closes $25 Mln Senior Secured Debt Facility
5/8/2019 4:02:39 PM AcelRx Pharma Q1 Loss/share $0.17 Vs. Loss $0.23 Year Ago
1/7/2019 8:37:10 AM AcelRx Publishes Data On Sufentanil Sublingual Tablets For Short-term Treatment Of Moderate-to-severe Acute Pain
11/9/2018 9:13:45 AM AcelRx Pharma Prices Public Offering Of 12.70 Mln Shares At $3.15/shr
11/9/2018 7:09:05 AM AcelRx Intends To Offer And Sell Proposed Public Offering Of Common Stock
10/12/2018 7:13:33 AM AcelRx Stock Trading Halted; FDA Advisory Committee To Review DSUVIA New Drug Application
9/11/2018 7:06:01 AM AcelRx Announces Date Of FDA Advisory Committee Meeting For DSUVIA; Says Target Action Date Under PDUFA Is Nov 3
8/8/2018 7:13:34 AM AcelRx Pharma Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares
7/12/2018 9:31:45 AM AcelRx Pharma Prices Underwritten Public Offering Of 7.27 Mln Shares At $2.75/shr
  
 
>